According to the 2023 Journal Citation Reports, the Impact Factor (IF) of ESMO Journals remains strong this year. Contributing to shape the oncology field by disseminating high-quality science and promoting discussions on cutting-edge topics, Annals of Oncology-Driving Innovation in Oncology, is now the 5th-ranked journal in oncology, with an IF of 50.5.
ESMO Open-Science for Optimal Cancer Care boasts an increased IF of 7.3, continuing to grow as an influential journal dedicated to publishing high-quality medical research and educational content from all disciplines in oncology, with a focus on innovative clinical and translational cancer research.
Two new editors-in-chief will be leading the journals as of January 2024: Tom Powles will be the new Editor-in-Chief of Annals of Oncology and Giuseppe Curigliano will take over ESMO Open.